CTL Communications made a strategic investment in Sacher AI in July 2024 to support the joint development of safe, effective AI-powered solutions that improve engagement and product impact in healthcare.
The partnership brings together Sacher AI's work in behaviour change and human-facing AI with CTL Communications' reach in healthcare communications. The shared aim is to build solutions that do more than raise awareness and instead help create meaningful behaviour change and measurable outcomes.
For Sacher AI, the announcement reflected strong market demand for combined AI and behavioural science support. The business had already begun working with leading digital health and wellness clients across the United States and Europe.
The broader strategic value is not just funding. It is the combination of communications expertise, commercial scale, and behavioural AI capability in one partnership, giving both organisations more room to build practical solutions for healthcare clients.
The investment also marked a new phase of growth for CTL Communications, whose team had expanded rapidly in recent years. With CTL's scale and Sacher AI's specialist insight working together, the partnership was positioned as a way to accelerate both companies and strengthen the solutions they bring to market.